Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H13N3O6 |
| Molecular Weight | 343.2909 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CNC(=O)C1=CC=C(C=C1)\N=N\C2=CC(C(O)=O)=C(O)C=C2
InChI
InChIKey=CQSRTOJJBONKMC-VHEBQXMUSA-N
InChI=1S/C16H13N3O6/c20-13-6-5-11(7-12(13)16(24)25)19-18-10-3-1-9(2-4-10)15(23)17-8-14(21)22/h1-7,20H,8H2,(H,17,23)(H,21,22)(H,24,25)/b19-18+
| Molecular Formula | C16H13N3O6 |
| Molecular Weight | 343.2909 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs. | 1999-07 |
|
| Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. | 1985-07-01 |
|
| Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. | 1983-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:13 GMT 2025
by
admin
on
Mon Mar 31 18:29:13 GMT 2025
|
| Record UNII |
499H4332KZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C73087
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
5222
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
SUB08289MIG
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
100000083128
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
9571082
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
80573-03-1
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104872
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
499H4332KZ
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY | |||
|
C038636
Created by
admin on Mon Mar 31 18:29:13 GMT 2025 , Edited by admin on Mon Mar 31 18:29:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLIC ENZYME -> SUBSTRATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
AMOUNT ADMINISTERED
URINE
|
||
|
METABOLITE ACTIVE -> PRODRUG | |||
|
METABOLITE -> PARENT |
AMOUNT ADMINISTERED
FECAL
|